Diamines as modulators of chemokine receptor activity
US6974836B2 · kind B2 · utility
11Cited by
12References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2001 |
| Grant date | Dec 13, 2005 |
| Priority date | — |
| Expiry date | Mar 3, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.